Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
SITC
Jun 10, 2024, 11:09 |
Insight
Phase II BLOSSOM Trial Osimertinib in LMD from EGFR+ NSCLC by Sehhoon Park et al.
Jarushka Naidoo shared a post on X: "Phase II BLOSSOM Trial Osimertinib in LMD (leptomeningeal…
Jun 9, 2024, 09:21 |
Blog
Eric K. Singhi: Remember to be kind to yourself
Eric K. Singhi shared a post by Mark Lewis, on X: "Mark Lewis is absolutely right. On…
Jun 8, 2024, 17:22 |
Blog
Roger Li: Final results of CORE001 trial at Nature Medicine
Roger Li, Urologic oncologist at Moffitt Cancer Center, shared on X/Twitter: "Final results of CORE001 trial…
May 31, 2024, 16:42 |
Blog
Jarushka Naidoo: My Top 5 Targeted Therapy abstracts at ASCO24 with key data where available
Jarushka Naidoo shared a post on X: "ASCO24 is tomorrow! Lung Cancer Abstracts not to missed,…
May 28, 2024, 14:59 |
Societies
Patrick Hwu: So excited to be back with The Check Points next Sunday at ASCO24
Patrick Hwu shared on X: "So excited to be back with The Check Points next…
May 21, 2024, 12:01 |
Blog
Jarushka Naidoo: Phase III trial methylphenidate versus placebo for cancer fatigue in advanced solid tumors
Jarushka Naidoo shared on X/Twitter: "Phase III trial methylphenidate versus placebo for cancer fatigue in advanced…
May 18, 2024, 09:06 |
Blog
Jarushka Naidoo: Perioperative Nivolumab in Stage IIA-IIIB NSCLC
Jarushka Naidoo shared on X/Twitter: ''Ph III CM77T trial at NEJM: Perioperative Nivolumab in Stage…
May 16, 2024, 16:51 |
Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
May 16, 2024, 09:30 |
Blog
Patrick Hwu: Excited to perform again with Society for Immunotherapy of Cancer's band
Patrick Hwu shared a post by Society for Immunotherapy of Cancer, on X: "Excited to perform…
May 13, 2024, 14:29 |
Insight
Jarushka Naidoo: A step forward in implementing anti-PD(L)1 across growing not otherwise specified of indications?
Jarushka Naidoo shared on X: "Ph III IMscin001 trial of Subcutaneous (sc) vs IV Atezolizumab…
8
9
10
11
12
All:
147
Posts:
91 - 100
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube